| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PNAS..110E.869D |
| P356 | DOI | 10.1073/PNAS.1213653110 |
| P932 | PMC publication ID | 3593905 |
| P698 | PubMed publication ID | 23431166 |
| P5875 | ResearchGate publication ID | 235691713 |
| P50 | author | Andreas Plückthun | Q23057697 |
| Annemarie Honegger | Q40005792 | ||
| P2093 | author name string | Victor Krasnykh | |
| Markus G Grütter | |||
| Peer R E Mittl | |||
| Natalya Belousova | |||
| Galina Mikheeva | |||
| Christian Hess | |||
| Birgit Dreier | |||
| Gabriela Nagy-Davidescu | |||
| P2860 | cites work | HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses | Q24312224 |
| Overexpression of IRS2 in isolated pancreatic islets causes proliferation and protects human beta-cells from hyperglycemia-induced apoptosis | Q24317713 | ||
| In vitro selection and evolution of functional proteins by using ribosome display | Q24643887 | ||
| Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR | Q27620424 | ||
| A designed ankyrin repeat protein evolved to picomolar affinity to Her2 | Q27644627 | ||
| High-affinity binders selected from designed ankyrin repeat protein libraries | Q28257550 | ||
| Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 | Q28303765 | ||
| Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment | Q29615852 | ||
| Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins. | Q30979207 | ||
| Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. | Q31967754 | ||
| The 'adenobody' approach to viral targeting: specific and enhanced adenoviral gene delivery | Q32162676 | ||
| Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target | Q33275939 | ||
| Folding and unfolding mechanism of highly stable full-consensus ankyrin repeat proteins. | Q33312735 | ||
| Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display | Q33360541 | ||
| Her2-specific multivalent adapters confer designed tropism to adenovirus for gene targeting | Q33740415 | ||
| Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells | Q33808695 | ||
| Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR. | Q33823521 | ||
| DARPins and other repeat protein scaffolds: advances in engineering and applications | Q33946122 | ||
| Genetic targeting of adenoviral vectors | Q33996499 | ||
| DARPins recognizing the tumor-associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency | Q34036904 | ||
| Ribosome display: a perspective | Q34077250 | ||
| Rapid selection of high-affinity binders using ribosome display | Q34077293 | ||
| Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size | Q34096303 | ||
| Development of a targeted gene vector platform based on simian adenovirus serotype 24. | Q34120794 | ||
| Designed ankyrin repeat proteins (DARPins) from research to therapy | Q34122106 | ||
| Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge | Q34226547 | ||
| Negative regulation of HER2 signaling by the PEST-type protein-tyrosine phosphatase BDP1. | Q34281830 | ||
| Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors | Q34282191 | ||
| Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement | Q34597583 | ||
| Separating fact from fiction: assessing the potential of modified adenovirus vectors for use in human gene therapy | Q34729600 | ||
| Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. | Q34781681 | ||
| How does your virus grow? Understanding and interfering with virus assembly | Q35587585 | ||
| The coxsackie-adenovirus receptor--a new receptor in the immunoglobulin family involved in cell adhesion. | Q35607448 | ||
| A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancer | Q35678429 | ||
| Bispecific designed ankyrin repeat proteins (DARPins) targeting epidermal growth factor receptor inhibit A431 cell proliferation and receptor recycling | Q35842099 | ||
| Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies | Q35870207 | ||
| Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. | Q35870225 | ||
| Gene therapy: twenty-first century medicine | Q36161193 | ||
| The influence of adenovirus fiber structure and function on vector development for gene therapy | Q36182171 | ||
| Genetic targeting strategies for adenovirus | Q36273182 | ||
| Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo | Q36535456 | ||
| Engineering targeted viral vectors for gene therapy | Q36868494 | ||
| Gene therapy clinical trials worldwide to 2007--an update. | Q36920192 | ||
| Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer | Q37291653 | ||
| Insights into adenovirus host cell interactions from structural studies | Q37329603 | ||
| Adenoviruses: update on structure and function | Q37352487 | ||
| Advances and future challenges in adenoviral vector pharmacology and targeting | Q37859842 | ||
| Tropism-modification strategies for targeted gene delivery using adenoviral vectors | Q38614156 | ||
| Adenovirus type 37 uses sialic acid as a cellular receptor | Q39588484 | ||
| Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein | Q39589919 | ||
| Functional and selective targeting of adenovirus to high-affinity Fcgamma receptor I-positive cells by using a bispecific hybrid adapter | Q39601286 | ||
| A novel fusion toxin derived from an EpCAM-specific designed ankyrin repeat protein has potent antitumor activity | Q39632060 | ||
| Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization | Q39682554 | ||
| Selective targeting of adenovirus to alphavbeta3 integrins, VEGFR2 and Tie2 endothelial receptors by angio-adenobodies | Q39730829 | ||
| Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. | Q39875310 | ||
| Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy | Q39876759 | ||
| Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. | Q39882081 | ||
| Genetically targeted adenovirus vector directed to CD40-expressing cells | Q40012083 | ||
| Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer | Q40055106 | ||
| Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule | Q40560830 | ||
| Use of recombinant adenovirus for metabolic engineering of mammalian cells. | Q40571045 | ||
| Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae | Q40917425 | ||
| Targeting adenoviruses with factor x-single-chain antibody fusion proteins | Q42533800 | ||
| Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificity | Q42808670 | ||
| A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo | Q42833222 | ||
| Facile double-functionalization of designed ankyrin repeat proteins using click and thiol chemistries | Q44324837 | ||
| Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity | Q45857523 | ||
| CD46 is a cellular receptor for group B adenoviruses | Q45869560 | ||
| Adenovirus serotype 5 hexon mediates liver gene transfer | Q45875068 | ||
| Adenovirus targeting to c-erbB-2 oncoprotein by single-chain antibody fused to trimeric form of adenovirus receptor ectodomain. | Q45882880 | ||
| Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity | Q50094012 | ||
| Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. | Q50895162 | ||
| Kinetic stability and crystal structure of the viral capsid protein SHP. | Q53881791 | ||
| Designed ankyrin repeat proteins: a novel tool for testing epidermal growth factor receptor 2 expression in breast cancer. | Q54672530 | ||
| Residue-Resolved Stability of Full-Consensus Ankyrin Repeat Proteins Probed by NMR | Q57839920 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | E869-77 | |
| P577 | publication date | 2013-03-05 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters | |
| P478 | volume | 110 |
| Q51238255 | 9th annual European Antibody Congress, November 11-13, 2013, Geneva, Switzerland. |
| Q57839812 | A Library-Based Screening Strategy for the Identification of DARPins as Ligands for Receptor-Targeted AAV and Lentiviral Vectors |
| Q24298137 | A code for RanGDP binding in ankyrin repeats defines a nuclear import pathway |
| Q47547452 | Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control. |
| Q42220090 | An application of capsid-specific artificial ankyrin repeat protein produced in E. coli for immunochromatographic assay as a surrogate for antibody |
| Q36333938 | Beyond Antibodies as Binding Partners: The Role of Antibody Mimetics in Bioanalysis |
| Q57059568 | Bispecific applications of non-immunoglobulin scaffold binders |
| Q36827348 | Conformation-dependent recognition of HIV gp120 by designed ankyrin repeat proteins provides access to novel HIV entry inhibitors |
| Q93015560 | DARPins: Promising Scaffolds for Theranostics |
| Q55467684 | Designer Oncolytic Adenovirus: Coming of Age. |
| Q35017003 | Mutation in fiber of adenovirus serotype 5 gene therapy vector decreases liver tropism |
| Q24567699 | New viruses for cancer therapy: meeting clinical needs |
| Q26776553 | Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications |
| Q33584756 | Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancer |
| Q38899428 | Recent progress in protein-protein interaction study for EGFR-targeted therapeutics |
| Q41330278 | Rigidly connected multispecific artificial binders with adjustable geometries. |
| Q90290727 | TRIM21-From Intracellular Immunity to Therapy |
| Q43791957 | Techniques and applications: Change of address for adenoviruses |
| Q93015565 | The Role of Interleukin-37 in the Pathogenesis of Allergic Diseases |
| Q91768182 | Unravelling Receptor and RGD Motif Dependence of Retargeted Adenoviral Vectors using Advanced Tumor Model Systems |
Search more.